Injectable, flexible electrode could replace rigid nerve-stimulating implants
By electrically stimulating nerves, neuromodulation therapies can reduce epileptic seizures, soothe chronic pain, and treat depression and a host of other health conditions without the use of conventional drugs like opioids.
Can ‘smart toilets’ be the next health data wellspring?
Wearable, smart technologies are transforming the ability to monitor and improve health, but a decidedly low-tech commodity — the humble toilet — may have potential to outperform them all.
Survey of the Health of Wisconsin team presents at international conference
From Aug. 25-28, SHOW team members Kristen Malecki, PhD, MPH; Amy Schultz, MS, and Alex Spicer attended the International Society for Environmental Epidemiology (ISEE) Conference in Utrecht, Netherlands.
Carbone Cancer Center oncologist identifies unconscious gender bias
When speaking at the world’s largest international oncology conference, female speakers were addressed less often by their professional title compared to male speakers, and were more likely to be introduced by their first name only.
UW researchers use stem cells to develop vocal folds in a dish
Researchers at University of Wisconsin School of Medicine and Public Health have created an in vitro 3-D model of human vocal fold tissue (called mucosa) that could improve our understanding and treatment of disorders affecting the human voice.
Biostatistics and medical informatics tapped for $11.8 million national coordinating center
A University of Wisconsin-Madison professor and his team have been chosen to lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network (CP-CTNet).
Cancer research conference focuses on targeted radionuclide therapy
University of Wisconsin-Madison is hosting a national conference on targeted radionuclide therapy (TRT), a promising new technology that combines cytotoxic radioisotopes with molecularly targeted agents to produce an anti-cancer therapy capable of treating local or systemic disease.
‘Clamp’ regulates message transfer between mammal neurons
A fundamental question in nerve biology brings to mind a race car at the starting line: The engine is revving, but the brake is on. The system is ready to go, but under tight control.
Electronic records pin broad set of health risks on genetic premutation
It was long believed the FMR1 premutation — an excessive number of trinucleotide repeats in the FMR1 gene — had no direct effect on the people who carry it. Until recently, the only recognized effect on the carriers of the flawed gene was the risk of having offspring with fragile X syndrome, a rare but serious form of developmental disability.
Changing a single molecule in the brain can alleviate anxiety
A new study shows, for the first time in primates, that altering one particular molecule in a specific brain region can change “dispositional anxiety,” the tendency to perceive many situations as threatening. The finding provides hope for new strategies focused on intervening early in life to treat people at risk for anxiety disorders, depression, and related substance abuse.
Single protein plays important dual shipping role in the brain
Just as a packaging breakdown can hamstring delivery of cables, switches and connectors to a house under construction, removing a protein from neurons can block the “shipment” of proteins to developing axons.
Study finds major surgery is associated with minor cognitive decline
A new study by researchers at the University of Wisconsin School of Medicine and Public Health has revealed that major surgery is associated with only a minor decline in cognitive ability.